zonisamide has been researched along with Dystonic Disorders in 3 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Dystonic Disorders: Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zonisamide was well-tolerated." | 2.82 | A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia. ( Apartis, E; Azulay, JP; Bissery, A; Bonnet, C; Brochard, V; Charbonnier-Beaupel, F; Clot, F; Corvol, JC; Cozic, N; Degos, B; Doe De Maindreville, A; Drapier, S; Dupont, S; Glibert, G; Grabli, D; Hainque, E; Hubsch, C; Lebouvier, T; Legrand, AP; Mallet, A; Méneret, A; Mutez, E; Roze, E; Thobois, S; Tranchant, C; Vidailhet, M; Zahr, N, 2016) |
| "Zonisamide was chosen for treatment of secondary paroxysmal dystonia in a patient with pyruvate dehydrogenase deficiency (case 1) and in two patients with neonatal hemochromatosis and family history of neonatal hemochromatosis (cases 2 and 3)." | 1.36 | Zonisamide ameliorates symptoms of secondary paroxysmal dystonia. ( Borenstein, MJ; Egel, RT; Hoganson, GE; Katerji, MA, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salamon, A | 1 |
| Zádori, D | 1 |
| Horváth, E | 1 |
| Vécsei, L | 1 |
| Klivényi, P | 1 |
| Hainque, E | 1 |
| Vidailhet, M | 1 |
| Cozic, N | 1 |
| Charbonnier-Beaupel, F | 1 |
| Thobois, S | 1 |
| Tranchant, C | 1 |
| Brochard, V | 1 |
| Glibert, G | 1 |
| Drapier, S | 1 |
| Mutez, E | 1 |
| Doe De Maindreville, A | 1 |
| Lebouvier, T | 1 |
| Hubsch, C | 1 |
| Degos, B | 1 |
| Bonnet, C | 1 |
| Grabli, D | 1 |
| Legrand, AP | 1 |
| Méneret, A | 1 |
| Azulay, JP | 1 |
| Bissery, A | 1 |
| Zahr, N | 1 |
| Clot, F | 1 |
| Mallet, A | 1 |
| Dupont, S | 1 |
| Apartis, E | 1 |
| Corvol, JC | 1 |
| Roze, E | 1 |
| Egel, RT | 1 |
| Hoganson, GE | 1 |
| Katerji, MA | 1 |
| Borenstein, MJ | 1 |
1 trial available for zonisamide and Dystonic Disorders
| Article | Year |
|---|---|
A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia.
Topics: Adolescent; Adult; Central Nervous System Agents; Cross-Over Studies; Disability Evaluation; Double- | 2016 |
2 other studies available for zonisamide and Dystonic Disorders
| Article | Year |
|---|---|
[Zonisamide treatment in myoclonus-dystonia].
Topics: Adult; Anticonvulsants; Child; Dystonic Disorders; Female; Humans; Myoclonus; Zonisamide | 2019 |
Zonisamide ameliorates symptoms of secondary paroxysmal dystonia.
Topics: Adolescent; Antioxidants; Child; Dystonic Disorders; Female; Hemochromatosis; Humans; Isoxazoles; Ma | 2010 |